- Release Date: 06/04/20 09:09
- Summary: FDA Clears IND for Remestemcel Use in COVID-19 ARDS Patients
- Price Sensitive: Yes
- Download Document 89.95KB
Ann: FDA Clears IND for Remestemcel Use in COVID-19 ARDS Patients
-
- There are more pages in this discussion • 311 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
96.0¢ |
Change
0.005(0.52%) |
Mkt cap ! $1.073B | |||
| Open | High | Low | Value | Volume |
| 96.0¢ | 98.5¢ | 91.5¢ | $3.717M | 3.927M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 19 | 23036 | 95.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 96.0¢ | 23945 | 14 |
View Market Depth
| Last trade - 14.53pm 29/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |